Cell-Based Assays Market based on Product & Service (Consumables, Instruments, and Services), Application (Drug Discovery, Basic Research, and Other Applications), End-User, and Geography – Global Forecast up to 2026

  • April, 2021
  • Domain: Healthcare - Pharmaceuticals
Pages: 97
Tables: 68
Charts: 101
Regions/Countries: 4 / 10
Companies: 13
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

Cell-based assays are versatile research lab tools employed in healthcare. These tools are designed to target particular cells by using antibodies or other moieties to determine drugs' functionality and efficiency. Also, cell-based assays facilitate the calculation of cell motility and growth and promote research in stem cells, immunology, cancer, and others. The factors driving the cell-based assays market are the rising number of chronic diseases such as cancer, diabetes, epilepsy, and the increasing elderly population. Additionally, the rapidly increasing drug discovery is anticipated to surge the demand for cell-based assays as it is majorly used in examining the efficacy of drugs. Various companies are included in the drug discovery, which increased cell-based assays for examining the new drugs that are expected to fuel the cell-based assays market in the forecast period. Despite the drivers of market growth, the market's restraining factors include high costs of the assays and shortage of skilled labor in this domain. The Cell-Based Assays Market is estimated to grow at the rate of 16.6% CAGR by 2026.

Research Methodology:

The Cell-based assays market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Low Power Wide Area Network Market

Cell-Based Assays Market based on Product & Service

  • Consumables
  • Reagents
  • Assay Kits
  • Probes & Labels
  • Microplates
  • Cell Lines
  • Instruments
  • Services

Cell-Based Assays Market based on Application

  • Drug Discovery
  • Basic Research
  • Other Applications

Cell-Based Assays Market based on End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Institutes
  • Contract Research Organizations

Cell-Based Assays Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The market is based on products & services, and this segment is further segmented into consumables, instruments, and services. The consumables segment is likely to hold the highest share in the market. The highest share is majorly ascribed to the increasing usage and requirement in the pre-requisite steps of cell-based assay methodologies

Based on the application of cell-based assays, the market is categorized into drug discovery, basic research, and other applications. The drug discovery segment is witnessing a significant growth rate in the market due to the increase in investments in research and developments for drug discovery by various biopharmaceutical companies and the development of drugs to treat multiple diseases.

Then further based on end-users, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, and Contract Research Organizations. The pharmaceutical and biotechnology companies segment has acquired a significant share in the market growth. This is due to the increasing demand for new drugs to treat various diseases among the rising elderly population globally. Rising competition among the healthcare companies and increasing research and development activities by pharmaceutical and biotechnology companies are the major factors boosting the segment growth.

In the regional market of cell-based assays, the North American region has occupied the market's substantial share. Factors including the presence of various numbers of pharmaceutical companies, drastically growing drug-based developments and research activities, and a rising number of well-established biotechnological laboratories are accelerating the region's market growth.

Cell-based assays occupy various advantages over conventional biochemical assays and animal models, and these advantages have majorly driven the rising demand for these assays in the present years. There is increasing usage of cell-based assays as the preferred tool for testing potential drug compounds and toxicity testing, increasing demand from the drug development companies. The cell-based assays demand will increase further due to increased allotment of resources to drug discovery by companies, the existence of many proteins of which functions are yet to be known, and the rising demand for biological drugs.

Prominent players of the market are Becton, Dickinson and Company, Charles River Laboratories, Inc., Cell Signaling Technology, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Lonza Group Ltd., Cell Biolabs, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Promega Corporation, Cisbio Bioassays, and Discoverx Corporation.

The cell-based assays are having a prominent role in the present scenario of a rising number of diseases worldwide in the discovery and development of drugs since these cell-based assays provide enormous benefits in screening all types of compounds.

  • This research segments the cell-based assays market entirely and gives the nearest evaluations of the complete market size and the sub-segments among significant regions.
  • This report provides insightful analyses of the market and provides a comprehensive understanding of the cell-based assays market and its commercial landscape.
  • Provides information about the market strategies which the competitors and leading organizations are adopting.
  • This report provides the perception of the future outlook and prospects for cell-based assays market analysis and forecast.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Product & Service: Market Size & Analysis
    1. Overview
    2. Consumables
      1. Reagents
      2. Assay Kits
      3. Probes & Labels
      4. Microplates
      5. Cell Lines
    3. Instruments
    4. Services
  6. Application: Market Size & Analysis
    1. Overview
    2. Drug Discovery
    3. Basic Research
    4. Other Applications
  7. End User: Market Size & Analysis
    1. Overview
    2. Pharmaceutical & Biotechnology Companies
    3. Academic & Government Institutes
    4. Contract Research Organizations
  8. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  9. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  10. Vendor Profiles
    1. Becton, Dickinson and Company
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. Charles River Laboratories, Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. Cell Signaling Technology, Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. Danaher Corporation
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. Thermo Fisher Scientific Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. Lonza Group Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. Cell Biolabs, Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    8. General Electric Company
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. Merck KGaA
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    10. Perkinelmer, Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  11. Companies to Watch
    1. Promega Corporation
      1. Overview
      2. Products & Services
      3. Business Strategy
    2. Cisbio Bioassays
      1. Overview
      2. Products & Services
      3. Business Strategy
    3. Discoverx Corporation
      1. Overview
      2. Products & Services
      3. Business Strategy
      4.  
  12. Analyst Opinion
  13. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase